Tech Company Financing Transactions
Jupiter Orphan Therapeutics Funding Round
On 1/7/2017, Jupiter Orphan Therapeutics announced $2.5 million in investment from Tarnagulla Ventures.
Transaction Overview
Company Name
Announced On
1/7/2017
Transaction Type
Venture Equity
Amount
$2,500,000
Round
Undisclosed
Investors
Tarnagulla Ventures (Natalie McNamee)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
601 Heritage Dr. 138
Jupiter, FL 33458
USA
Jupiter, FL 33458
USA
Phone
Undisclosed
Website
Email Address
Overview
Jupiter Orphan Therapeutics, Inc. (JOT) is a clinical stage specialty pharmaceutical company developing therapies for rare diseases linked to single gene deficiencies. JOT, a Delaware Corporation with it's principal office located in Jupiter, FL, USA, was founded in the summer of 2015.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Christer Rosén
Chief Financial Officer
Jacob Uittenbogaard
Chief Medical Officer
Claes Wahlestedt
Chief Scientific Officer
Marshall Hayward
VP - R & D
Shaun Brothers
Browse more venture capital transactions:
Prev: 1/7/2017: Payfone venture capital transaction
Next: 1/7/2017: RxREVU venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs